Correlated alterations in prostate basal cell layer and basement membrane

International Journal of Biological Sciences

Volumn 5, Issue 3, 2009, Pages 276-285

  Liu, Aijun ^a   Wei, Lixin ^a   Gardner, William A ^b   Deng, Chu Xia ^b   Man, Yan Gao ^c  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Basement membrane; Focal basal cell layer disruption; Prostate tumors

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P63; CKAP4 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ARTICLE; BASAL CELL; BASEMENT MEMBRANE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOLECULAR MECHANICS; PROSTATE EPITHELIUM; PROSTATE TUMOR; TUMOR GROWTH; CHEMISTRY; MALE; PATHOLOGY; PROSTATE;

BASEMENT MEMBRANE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 65349178453     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.5.276     Document Type: Article

References (55)

1. Carruba G, Stefano R, Cocciaeliferro L. Intercellular communication and human prostate carcinogenesis. Ann NY Acad Sci. 2002; 963:156-168 (Pubitemid 34721708)
2. Goldstein NS, Underhiel J, Roszka N, Neill JS. Cytokeratin 34 beta E-12 immunoreactivity in benign prostate acini. Quantitation, pattern assessment, and electron microscopic study. Am J Clin Pathol. 1999; 112:69-74.
3. Bonkhoff H, Wernert N, Dhom G, Remberger K. Basement membranes in fetal, adult normal, hyperplastic and neoplastic human prostate. Virchows Arch A Pathol Anat Histopathol. 1991; 418:375-381
4. Kosir MA, Wang W, Zukowski KL, Tromp G. Degradation of basement membrane by prostate tumor heparanase. J Surg Res. 1999; 81:42-47 (Pubitemid 29393775)
5. Bonkhoff H, Remberger K. Morphogenesis of benign prostatic hyperplasia and prostatic carcinoma. Pathology. 1998; 19:12-20. (Pubitemid 28109257)
6. Bostwick DG. Prospective origins of prostate carcinoma. Prostate intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer. 1996;78: 330-336
7. Haggman MJ, Macoska JA, Wojno KJ, Oesterling JE. The relationship between prostate intraepithelial neoplasia and prostate cancer: critical issues. J Urol. 1997; 58:12-22. (Pubitemid 27251585)
8. Bonkhoff H, Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate. 1996;28: 98-106. (Pubitemid 26066247)
9. Barsky SH, Siegal GP, Jannotta F, Liotta LA. Loss of basement membrane components by invasive tumors but not by the benign counterparts. Lab Invest. 1983; 49:140-147
10. Goldfarb RH, Liotta LA. Proteolytic enzymes in cancer invasion and metastasis. Semin Thromb Hemost. 1986; 12: 294-307.
11. Gardner WA, Culberson DE. Atrophy and proliferation in the young adult Prostate. J Urol. 1987;137(1):53-56
12. Gardner WA. Hypothesis: Pediatric Origins of Prostate Cancer. Hum Path 1995; 26:1291-1292.
13. Bennett BD, Gardner WA. Embryonal hyperplasia of the prostate. Prostate. 1985; 3 (7): 411-417
14. Malins DC, Polissar NL, Su Y, Gardner HS, Gunselman SJ. A new structural analysis of DNA using statistical models of infrared sepctra. Nat Med. 1997; 3: 927-930 (Pubitemid 27353457)
15. Malins DC, Johnson PM, Barker EA, et al. Cancer-related changes in prostate DNA as men age and early identification of metastasis in prostate tumors. Proc Natl Acad Sci USA. 2003; 100: 5401-5406
16. Malins DC, Anderson KM, Gilman NK, et al. Development of a cancer DNA phenotype prior to tumor formation. Proc Natl Acad Sci Sci USA. 2004; 101:10721-10725
17. Malins DC, Gilman NK, Green VM, et al. A DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesis. Proc Natl Acad Sci USA. 2005; 102: 19093-19096
18. Ashida S, Nakagawa H, Katagiri T, Furihata M, Liizumi M, Anazawa Y, et al. Molecular features of the transition from prostate intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res. 2004; 64:5963-5972 (Pubitemid 39129392)
19. Dawkins HJ, Sellner LN, Turbett GR, Thompson CA, Redmond SL, MeNeal JE, Cohen RJ. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adecarcinoma, using molecular markers of cancer progression. Prostate. 2000; 44:265-270
20. Harvei S, Skijorten FJ, Robsahm TE, Berner A, Tretli S. Is prostaticibtraepithelial neoplasi in the transitio/central zone a true presursor of cancer? A long-tern retrospective study in Norway. Br J Cancer. 1998; 78:46-49 (Pubitemid 28276768)
21. Goeman L, Joniau S, Ponette D, Van der Aa F, Roskams T, Oyen R, Van Poppel H. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer. Prostate Cancer Prostatic Dis. 2003; 6:305-310 (Pubitemid 38088193)
22. Mostofi FK, Sesterhenn IA, Davis CJJr. Prostatic intraepithelial neoplasia (PIN): morphological clinical significance. Prostate Suppl. 1992; 4:71-77
23. Kasahara Y, Tsukada Y. New insights and future advances in cancer diagnostics: Limitations of conventional tumor markers. In: Nakarnura RM, Grody WW, Wu JT, Nagle RB, editors. Cancer Diagnostics: Current and future trends. Totowa, NJ: Humanna Press; 2004.
24. Joniau S, Goeman L, Pennings J, Van Poppel H. Prostatic intraepithelial neoplasia (PIN): importance and clinical managment. Eur Urol. 2005; 48:379-385 (Pubitemid 41188391)
25. Haggman MJ, Adolfsson J, Khoury S, Montie JE, Norlen J. Clinical managment of premalignant lesions of the prostate. WHO Collaborative Project and Consensus Conference on Public Health and Clinical Significance of Premalignant Alterations in the Genitourinary Tract. Scand J Urol Nephol Suppl. 2000; 205:44-49
26. Parker SL, Tong T, Bolders S, Wingo PA. Cancer statistics. Cancer J Clin. 1997;47: 5-27.
27. Bostwick DG. Prostatic intraepithelial neoplasia is a risk factor for cancer. Semin Urol Oncol. 1999; 17:187-189
28. Bostwick DG, Qian J, Frankel K. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol. 1985; 154: 1791-1794
29. Signoretti S, Waltregny D, Dilks J, et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol. 2000; 157:1769-1775
30. Kurita T, Medina RT, Mills AA, Cunha GR. Role of p63 and basal cells in prostate. Development. 2004; 131: 4955-4964 (Pubitemid 39485353)
31. Zou Z, Zhang W, Young D, et al. Maspin expression profile in human prostate cancer (caP) and in vitro induction of maspin expression by androgen ablation. Clin Cancer Res. 2002; 8(5):1172-1177 (Pubitemid 34517655)
32. Cher ML, Biliran HR jr, Bhangat S, et al. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in animal model of prostate cancer bone metastasis. Proc Natl Acad Sci USA. 2003; 100(13):7847-7852 (Pubitemid 36760058)
33. Man YG, Shen T, Zhao YG, Sang QXA. Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: A potential mechanism for basal cell layer degradations and tumor invasion. Cancer Detect Prev. 2005; 29:161-169 (Pubitemid 40501853)
34. Man YG, Zhao CQ, Wang J, XL Chen. A subset of prostate basal cells lacks corresponding phenotypic markers. Pathology-Research & Practice. 2006; 202 (9): 651-662
35. Man YG, Gardner WA. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion. Med Hypoth. 2008; 70:387-408.
36. Man YG, Gardner WA. Bad seeds produce bad crops: a single step-process of prostate carcinogenesis and Progression. Int J Biol Sci. 2008; 4: 246-258.
37. Verona EV, Elkahloum AG, Yang J, Bandyopadhyay A, Yeh IT, Sun LZ. Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling. Cancer Res. 2007; 67(12):5737-5746 (Pubitemid 46985006)
38. Zhou W, Grandis JR, Wells A. STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines. Br J Cancer. 2006; 95(2):164-171 (Pubitemid 44050915)
39. Chung IW, Baseman A, Assikis V, Zhau HE. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol. 2005;173(1):10-20. (Pubitemid 39627663)
40. Boulikas T. Control of DNA replication by protein phosphorylation. Anticancer Res. 1994; 14: 2465-2472
41. Boulikas T. Phosphorylation of transcription factors and control of the cell cycle. Crit Rev Eukaryot Gene Expr. 1995; 5: 1-77.
42. Chakravarthy MV, Spangenhurg EE, Booth FW. Culture in low levels of oxygen enhances in vitro proliferation potential of satellite cells from old skeletal muscles. Cell Mol Life Sci. 2001; 58: 1150-1158
43. Csete M, Walikonis J, Slawny N, et al. Oxygen-mediated regulation of skeletal muscle satellite cell proliferation and adipogrnesis in culture. J Cell Physical. 2001; 189:189-196 (Pubitemid 32946030)
44. Studer L, Csete M, Lee SH. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowed pxygen. J Neurosci. 2000; 20: 7377-7383 (Pubitemid 30747434)
45. Klos KS, Wyszomierski SL, Sun M et al. c-erbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells. Cancer Res. 2006; 66(4): 2028-2037
46. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Vasculogenic mimicry and tumor-cell plasticity: lessons from melanoma. Nat Rev Cancer. 2003; 3(6): 411-421
47. Kang Y, Massague J. Epithelial-mesenchymal transition: twist in development and metastasis. Cell. 2004; 118: 277-279 (Pubitemid 39061108)
48. Sato T, Sakai T, Noguchi Y, Takita M, Hirakawa S, Ito A. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol Oncol. 2004; 92: 47-56. (Pubitemid 38147370)
49. Strizzi L, Bianco C, Normanno N. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Criptol-1 transgenic mice. J Cell Physiol. 2004; 201:266-276 (Pubitemid 39305104)
50. Gardner WA. "Pathology Paradigms". In: Coffey D, Bruchovsky N, Gardner W, Resnick M, Karr J, Eds. Current Concepts and Approaches to the Study of Prostate Cancer. NY: A R Liss. 1987.
51. Smith, CJ, Gardner WAJr. Inflammation - Proliferation: Possible Relationships in the Prostate. In: Coffey D, Bruchovsky N, Gardner W, Resnick M, Karr J, Eds. Current Concepts and Approaches to the Study of Prostate Cancer. NY: A R Liss. 1987.
52. Nelson G, Culberson DE, Gardner WA. Intraprostatic Spermatozoa. Hum Path. 1988; 19(1): 119-120
53. Gardner WA, Bennett BD. The Prostate - Overview: Recent Insights and Speculations. In: WA. Gardner and RS Weinstein (Eds.) Pathology and Pathobiology of Urinary Bladder and Prostate. Williams and Wilkins, Baltimore, MD, 1992.
54. Peek RM Jr, Mohla S, DuBois RN. Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting. Cancer Res. 2005; 65: 8583-8586 (Pubitemid 41377339)
55. MacLennan GT, Eisenberg R, Fleshman RL et al. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year follow-up study. J Urol. 2006; 176: 1012-1016 (Pubitemid 44142579)